Rutin and selenium nanoparticles protected against STZ-induced diabetic nephropathy in rats through downregulating Jak-2/Stat3 pathway and upregulating Nrf-2/HO-1 pathway

This publication has 31 references indexed in Scilit:

• JAK inhibition in the treatment of diabetic kidney disease
  Diabetologia, 2016
• Diabetic nephropathy: landmark clinical trials and tribulations
  Nephrology Dialysis Transplantation, 2015
• Selenium nanoparticles involve HSP-70 and SIRT1 in preventing the progression of type 1 diabetic nephropathy
  Chemico-Biological Interactions, 2014
• Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans
  Journal of Diabetes & Metabolic Disorders, 2013
• Inflammation and Oxidative Stress in Diabetic Nephropathy: New Insights on Its Inhibition as New Therapeutic Targets
  Journal of Diabetes Research, 2013
• Allopurinol, quercetin and rutin ameliorate renal NLRP3 inflammasome activation and lipid accumulation in fructose-fed rats
  Biochemical Pharmacology, 2012
• Blockade of Oxidized LDL-Triggered Endothelial Apoptosis by Quercetin and Rutin through Differential Signaling Pathways Involving JAK2
  Journal of Agricultural and Food Chemistry, 2009
• Elemental Selenium at Nano Size (Nano-Se) as a Potential Chemopreventive Agent with Reduced Risk of Selenium Toxicity: Comparison with Se-Methylselenocysteine in Mice
  Toxicological Sciences, 2007
• Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction
  Analytical Biochemistry, 1979
• Tissue sulfhydryl groups
  Archives of Biochemistry and Biophysics, 1959